Ziyue Zhou

机构：Yangtze River Pharmaceutical Group (China) · ORCID：0000-0002-6580-4419

发表论文 46 篇 · 总被引 610 次 · h-index 13

代表论文

• 68 Ga-FAPI PET/CT for Rheumatoid Arthritis: A Prospective Study (2023 · Radiology · 被引 77)
• Single-cell profiling identifies IL1Bhi macrophages associated with inflammation in PD-1 inhibitor-induced inflammatory arthritis (2024 · Nature Communications · 被引 41)
• [68 Ga]Ga-FAPI-04 PET/CT may be a predictor for early treatment response in rheumatoid arthritis (2024 · EJNMMI Research · 被引 23)
• SKN‐1/NRF2 upregulation by vitamin A is conserved from nematodes to mammals and is critical for lifespan extension in Caenorhabditis elegans (2023 · Aging Cell · 被引 22)
• Titanium hexacyanoferrate/carbon nanotube composites as the cathode material for aqueous sodium/zinc ion batteries (2024 · Journal of Power Sources · 被引 14)
• Silver Jubilee of HER2 targeting: a clinical success in breast cancer (2025 · Journal of the National Cancer Center · 被引 10)